Bevacizumab-Induced Reversible Thrombocytopenia in a Patient with Adenocarcinoma of Colon: Rare Adverse Effect of Bevacizumab

We report a case of bevacizumab- (BEV-) induced thrombocytopenia in a 59-year-old man with adenocarcinoma of colon. After colectomy, the patient was treated with twelve cycles of FOLFOX-4 (folinic acid, 5-fluorouracil, and oxaliplatin) regimen. On relapse, he was treated with FOLFIRI (folinic acid,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Jeevan, Bhargava, Manorama, Aggarwal, Shyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474967/
https://www.ncbi.nlm.nih.gov/pubmed/23094167
http://dx.doi.org/10.1155/2012/695430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474967/
https://www.ncbi.nlm.nih.gov/pubmed/23094167
http://dx.doi.org/10.1155/2012/695430

Ejemplares similares